Cite
Neoadjuvant and Adjuvant Immunotherapy in Resectable NSCLC.
MLA
Bogatsa, Evangelia, et al. “Neoadjuvant and Adjuvant Immunotherapy in Resectable NSCLC.” Cancers, vol. 16, no. 9, May 2024, p. 1619. EBSCOhost, https://doi.org/10.3390/cancers16091619.
APA
Bogatsa, E., Lazaridis, G., Stivanaki, C., & Timotheadou, E. (2024). Neoadjuvant and Adjuvant Immunotherapy in Resectable NSCLC. Cancers, 16(9), 1619. https://doi.org/10.3390/cancers16091619
Chicago
Bogatsa, Evangelia, George Lazaridis, Chrysoula Stivanaki, and Eleni Timotheadou. 2024. “Neoadjuvant and Adjuvant Immunotherapy in Resectable NSCLC.” Cancers 16 (9): 1619. doi:10.3390/cancers16091619.